Retinal and Choroidal Changes in Neurofibromatosis Type 1 in Relation to Diagnostic Criteria and Disease Severity

View at publisher
Authors: Figen Bezci Aygün, Burçak Karaca, Merve Özge Algedik Tokyürek, Sibel Öz Yıldız, Yasemin Kapucu Yatağanbaba, Rahşan Göçmen, Göknur Haliloğlu, Sibel Kadayıfçılar
Cited by: 1
References: 27

Abstract

Purpose To evaluate choroidal abnormalities in neurofibromatosis type 1 (NF1) using near-infrared reflectance (NIR) and en face optical coherence tomography angiography (OCTA), and to assess their associations with retinal and choroidal structural and microvascular parameters across diagnostic criteria and disease severity.Methods Fifty-two NF1 cases and 52 age- and sex-matched controls underwent multimodal imaging (SD-OCT, EDI-OCT, OCTA). Eye-level analyses used generalized estimating equations to account for inter-eye correlation. Multiple comparisons were controlled by the Benjamini–Hochberg false discovery rate (FDR).Results NIR detected choroidal abnormalities in 69.2% of NF1 cases, while en face OCTA identified corresponding lesions in 57.7%. NF1 eyes showed significantly reduced subfoveal choroidal thickness (SFCT, FDR adj p < 0.001) and higher superficial capillary plexus (SCP) vessel density and perfusion (FDR adj p = 0.012 for each). Deep capillary plexus (DCP) vessel density decreased with increasing disease severity in unadjusted analysis but lost significance after FDR adjustment. Apparent differences in age, central macular thickness (CMT), and FAZ circularity also became nonsignificant after adjustment.Conclusions NIR is more sensitive than OCTA for detecting choroidal abnormalities, whereas OCTA provides complementary quantitative insights. Reduced SFCT confirms choroidal involvement in NF1, and higher SCP metrics may reflect early remodeling or endothelial dysregulation. Larger, longitudinal studies are needed to validate DCP changes as potential markers of disease burden.

Fields of Study & Subjects

Neurofibromatosis and Schwannoma Cases Tuberous Sclerosis Complex Research Ocular Oncology and Treatments

Publication details

Journal / source
Current Eye Research
Publisher
Informa UK Limited
Volume
51
Issue
5
Pages
561–568
Publication date
4 March 2026
Language
EN